![]() 2025 AAHFN CEC Symposium - Facing the Challenges: Managing Hyperkalemia in Heart Failure Patients While Maintaining RAASi TherapyThis CME Symposium takes place on Thursday, June 12, 2025, from 11:15 AM - 12:15 PM ET during the AAHFN Annual Meeting at the Savannah Convention Center in Savannah, Georgia.
By: CMEPlanet Click here for more information CHAIR Marie Galvao, MSN, ANP-BC, CHFN, HF-Cert Lead Heart Failure Nurse Practitioner Center for Advanced Cardiac Therapy Montefiore Medical Center Bronx, New York FACULTY Stephen Greene, MD Associate Professor of Medicine Duke University School of Medicine Duke Clinical Research Institute Durham, North Carolina Lisa Rathman, MSN, CRNP, ACNP-BC, CHFN Lead Nurse Practitioner Heart Failure Section Penn Medicine Lancaster General Health Lancaster, Pennsylvania Educational Objectives - Explain the relationship between down-titration or discontinuation of RAASi therapy and clinical outcomes - Interpret evidence from clinical trials of novel potassium binders for the treatment of hyperkalemia - Identify HF patients who would benefit from potassium-lowering pharmacological therapy Target Audience This educational activity is intended for Heart Failure Nurses. Educational Grant AAHFN and Voxmedia International gratefully acknowledge the educational grant provided by AstraZeneca Pharmaceuticals. Continuing Education Credits AAHFN and Voxmedia International gratefully acknowledge the educational grant provided by AstraZeneca Pharmaceuticals. End
|